脂肪因子
大豆黄酮
内分泌学
内科学
脂联素
促炎细胞因子
脂肪组织
切梅林
胰岛素抵抗
脂肪细胞
炎症
瘦素
化学
染料木素
医学
胰岛素
肥胖
作者
Yuri Saho Sakamoto,A. Naka,Nozomi Ohara,Kazuo N. Kondo,Kaoruko Iida
标识
DOI:10.1002/mnfr.201300482
摘要
SCOPE: Daidzein was recently reported to act like an activator of peroxisome proliferator-activated receptor γ (PPARγ) thereby enhancing differentiation of adipocytes. Although PPARγ plays a role in adipokine expression, it has not been well researched whether daidzein affects expression of adipokines. This study aimed to clarify the effects of daidzein on proinflammatory adipokines and adipose inflammation causing insulin resistance in obesity. METHODS AND RESULTS: 3T3-L1 adipocytes were treated with daidzein or genistein. Diet-induced obese C57BL/6J mice were fed high-fat high-sucrose diets with daidzein (1.0 g/kg chow) for 12 wk. The results showed that both isoflavones, especially daidzein, stimulated adipogenic differentiation in 3T3-L1 adipocytes with the activation of PPARγ. Daidzein also increased adiponectin expression and decreased MCP-1 expression with the consistent regulation of their secretion. In obese mice, daidzein inhibited hypertrophy in fat cell size and improved insulin sensitivity, concomitant with upregulation of PPARγ in fat tissue. Decreased expression of MCP-1 and TNF-α, and increased expression of adiponectin were also observed in adipose tissue of daidzein-fed mice. Additionally, daidzein administration significantly inhibited macrophage accumulation in adipose tissue. CONCLUSION: Daidzein regulates adipokine expression through the PPARγ, thereby improving the adverse effects of adipose inflammation, such as insulin resistance, in obesity.
科研通智能强力驱动
Strongly Powered by AbleSci AI